C4 Therapeutics, Inc.·4

Sep 24, 4:51 PM ET

Prokupets Elena 4

4 · C4 Therapeutics, Inc. · Filed Sep 24, 2021

Insider Transaction Report

Form 4
Period: 2021-09-22
Transactions
  • Sale

    Common Stock

    2021-09-23$51.08/sh1,007$51,435506,552 total(indirect: By ERP Business Holdings, LP)
  • Sale

    Common Stock

    2021-09-24$50.10/sh2,115$105,964504,437 total(indirect: By ERP Business Holdings, LP)
  • Sale

    Common Stock

    2021-09-22$50.10/sh3,544$177,55439,492 total(indirect: By Spouse)
  • Sale

    Common Stock

    2021-09-23$50.35/sh5,926$298,35933,566 total(indirect: By Spouse)
  • Sale

    Common Stock

    2021-09-22$50.09/sh7,004$350,860519,360 total(indirect: By ERP Business Holdings, LP)
  • Sale

    Common Stock

    2021-09-23$51.09/sh446$22,78433,120 total(indirect: By Spouse)
  • Sale

    Common Stock

    2021-09-23$50.35/sh11,801$594,193507,559 total(indirect: By ERP Business Holdings, LP)
  • Sale

    Common Stock

    2021-09-24$50.11/sh900$45,10132,220 total(indirect: By Spouse)
Footnotes (9)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.31. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F5]Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
  • [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.99. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.04 to $51.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F8]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.00 to $51.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F9]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION